header
Image from OpenLibrary

Role of Apelin/APJ system in rat model of hepatic ischemia reperfusion injury : Possible interaction between apelin/APJ system and Ang S/AT1R system- Implication of endothelial nitric oxide / Basant Adel Aldreny ; Supervised Maha Mohamed Sabry , Laila Ahmed Elsaid , Nagwa Mahmoud Ramadan

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Basant Adel Aldreny , 2016Description: 180 P. : charts , facsimiles ; 25cmOther title:
  • دور نظام الابيلين فى نموذج الفئران المصابه بالايذاء الناتج عن القصور الشرياني واعادة الارتواء في الكبد : التداخل المحتمل بين نظام الابيلين ونظام الانجيوتينسين والانزيم الصانع لاكسيد النيتريك الباطاني [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Physiology Summary: Background: Apelin with its G-protein-coupled receptor APJ system and renin - angiotensin system (RAS) have opposing actions on ischemia/reperfusion (I/R) injury. Objective: The purpose of the present study is to evaluate the possible hepato-protective effect of apelin and losartan on hepatic I/R injury in rat model and to clarify the possible interaction between Apelin/APJ system, RAS system and endothelial nitric oxide synthase (eNOS) and its impact on progression of hepatic dysfunction. Methods: Ninety male albino rats were divided to six groups (n=15): control sham- operated group, hepatic I/R group, apelin +I/R group , apelin + (L-NAME) non selective endothelial nitric oxide synthase inhibitor + I/R group, losartan +I/R group and Losartan + (L-NAME) + I/R group. All hepatic I/R groups underwent 30 minutes of ischemia followed by 2 hours of reperfusion. Apelin was injected intraperitoneally daily (2 æg/kg/day) starting 3 days prior to surgical hepatic I/R procedure. Losartan was given orally by syringe (30 mg/kg / day) daily 2 weeks prior to surgical hepatic I/R procedure. L-NAME was injected intraperitoneally (10 mg/kg/day) daily 2 weeks prior to surgical hepatic I/R procedure. At the end of the 2 weeks immediately after hepatic I/R procedure, blood samples were taken for examining serum level of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). In addition, hepatic tissue was excised for estimation of hepatic gene expression of caspase-3 (CASP-3), endothelial nitric oxide synthase (eNOS) and Ang II type 1 receptor (AT1R) and level of malondialdehyde (MDA) and apelin in hepatic tissue. Finally, the rest of liver tissues were prepared for histopathological examination
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.30.Ph.D.2016.Ba.R (Browse shelf(Opens below)) Not for loan 01010110072974000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.30.Ph.D.2016.Ba.R (Browse shelf(Opens below)) 72974.CD Not for loan 01020110072974000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Physiology

Background: Apelin with its G-protein-coupled receptor APJ system and renin - angiotensin system (RAS) have opposing actions on ischemia/reperfusion (I/R) injury. Objective: The purpose of the present study is to evaluate the possible hepato-protective effect of apelin and losartan on hepatic I/R injury in rat model and to clarify the possible interaction between Apelin/APJ system, RAS system and endothelial nitric oxide synthase (eNOS) and its impact on progression of hepatic dysfunction. Methods: Ninety male albino rats were divided to six groups (n=15): control sham- operated group, hepatic I/R group, apelin +I/R group , apelin + (L-NAME) non selective endothelial nitric oxide synthase inhibitor + I/R group, losartan +I/R group and Losartan + (L-NAME) + I/R group. All hepatic I/R groups underwent 30 minutes of ischemia followed by 2 hours of reperfusion. Apelin was injected intraperitoneally daily (2 æg/kg/day) starting 3 days prior to surgical hepatic I/R procedure. Losartan was given orally by syringe (30 mg/kg / day) daily 2 weeks prior to surgical hepatic I/R procedure. L-NAME was injected intraperitoneally (10 mg/kg/day) daily 2 weeks prior to surgical hepatic I/R procedure. At the end of the 2 weeks immediately after hepatic I/R procedure, blood samples were taken for examining serum level of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). In addition, hepatic tissue was excised for estimation of hepatic gene expression of caspase-3 (CASP-3), endothelial nitric oxide synthase (eNOS) and Ang II type 1 receptor (AT1R) and level of malondialdehyde (MDA) and apelin in hepatic tissue. Finally, the rest of liver tissues were prepared for histopathological examination

Issued also as CD

There are no comments on this title.

to post a comment.